Critical limb ischemia (CLI) is a diagnosis plagued by significant comorbidity and high mortality rates. Overall survival remains poor in this population regardless of the procedure-related success as demonstrated by freedom from amputation, intervention, and patency. The literature has traditionally focused on physician-centered and lesion-centered outcomes with regards to limb salvage procedures, but there remains a relative paucity of studies of CLI patients describing patient-centered outcomes such as quality of life (QoL), independent living, and ambulation status. Review of the available literature indicates patients do not always experience significant gains in their QoL after limb salvage interventions, despite reasonable graft patency, amputation-free survival, and limb salvage rates. Further research is required using QoL tools in a measurable and clinically relevant fashion to guide optimal quality care that maximizes patient-centered outcomes. (J Vasc Surg 2017;65:571-8.) The TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) II guidelines define critical limb ischemia (CLI) as chronic ischemic rest pain or ischemic skin lesions.
The TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) II guidelines define critical limb ischemia (CLI) as chronic ischemic rest pain or ischemic skin lesions. 1 This diagnosis portends a decreased life expectancy, reflecting the systemic nature of advanced atherosclerotic disease and multiple comorbid conditions. Surgical and catheter-based interventions are frequently indicated in this population to salvage affected limbs. Mortality rates remain high despite acceptable limb salvage rates. In recent years, patient-centered outcomes of functional recovery and quality of life (QoL) in CLI populations have been afforded greater awareness, thus complementing the more commonly studied physiciancentered outcomes of postprocedural patency and limb salvage. We provide a review of the available evidence concerning QoL after surgical or endovascular intervention for patients with CLI.
EARLY PATIENT-CENTERED ASSESSMENTS
Functional status was one of the first patient-centered outcomes studied after lower extremity bypass surgery. Abou-Zamzam et al 2 assessed independent living and ambulation status in CLI patients undergoing infrainguinal bypass. Assessments were made preoperatively and at 6 months of follow-up. The findings were quite favorable: 99% of patients living independently preoperatively were still living independently at the 6-month follow-up. Ambulation status was also well preserved, with 97% of patients who were ambulatory preoperatively remaining so at the 6-month follow-up. Chung et al 3 also evaluated these features of functional status in CLI patients after infrainguinal bypass and reported similar results. Their review found 91% of surviving patients were living independently at 6 months compared with 96% before the development of CLI. Ambulatory status, however, decreased from 91% preoperatively to 72% at the 6-month follow-up. Taylor et al 4 provided insight to the durability of these same end points in patients 5 years after open surgical revascularization. The authors reported nonstratified results of suprainguinal and infrainguinal revascularizations as well as endovascular interventions. At 5 years, 71% maintained ambulatory status and 81% maintained independent living status. Patients are living longer, and as a result, interventions for CLI are more frequently performed in elderly patients. Functional recovery and QoL in these aged populations has thus come under increasing scrutiny. Given time, a patient who undergoes surgical or endovascular revascularization for CLI will likely require multiple secondary interventions to maintain arterial or graft patency. These procedures have the potential to add morbidity, but subsequent procedures appear to have less detrimental effects on the patient's functional status than the initial procedure. 5 Pomposelli et al 6 reviewed their experience over
5 years with open lower extremity revascularizations in patients aged >80 years at the time of their initial procedure. They evaluated graft patency, limb salvage, and survival along with functional status and independence. CLI was the indication in 96% of the included 299 procedures. Secondary patency rates were 87%, and limb salvage was 92%; however, only 44% were alive at 5 years (28% survival if they progressed to subsequent major amputation). They used a nonvalidated scoring system to compare functional status and independence, which served as surrogates for determining the patient's QoL. Preoperative ability to ambulate and independent living were independent predictors for postoperative independent ambulation and independent living. Analyses demonstrated that ambulation and independence were preserved or improved after surgical revascularization. Careful review of these data demonstrates that although 92% of the patients were ambulatory preoperatively, more than half required assist devices after their operation, and 5% were nonambulatory at 1 year. 9 These patients were randomized to surgical revascularization with a vein bypass performed after the conduit was treated with edifoligide or placebo. 10 QoL surveys were reviewed and suggested that patients receiving surgical bypass had improvement from their baseline QoL by 3 months postintervention and that this was maintained at the 1-year follow-up. An important limitation recognized in this study, and echoed in many others, was the decreasing percentage of patients completing QoL questionnaires at each follow-up interval: 92% at baseline, 61% at 3 months, and 52% at 1 year. The nonresponders were found to have a significantly higher rate of adverse events, such as need for repeat procedures or amputation, and were noted to be of nonwhite race or to have diabetes. This high attrition rate of QoL follow-up in patients with CLI may be attributed to the overall frailty of the CLI population, mortality, or social dependence on others for followup. The PREVENT III does, however, strongly suggest an ideal outcome from surgical revascularization improves QoL for the CLI patient. It seems intuitive that a patent bypass or intervention would result in a better functioning limb and, therefore, QoL, but a recent report by the Vascular Study Group of New England suggests this is not always the case. 11 In this study, 78% of 1012 patients who underwent surgical revascularization for CLI had a patent bypass at 1 year of follow-up. Treatment failure, noted as persistent rest pain, tissue loss, or a major amputation despite the finding of a patent bypass, was identified in 10% of these patients. Factors associated with this outcome included dialysis dependence and preoperative nonambulatory status. 
CONTEMPORARY QoL INSTRUMENTS

QoL MEASURES AFTER ENDOVASCULAR AND OPEN REVASCULARIZATION FOR CLI
A small yet reasonable volume of literature has been published regarding QoL in CLI patients after open surgical revascularization, but there is a paucity in the literature in the CLI patient population after an endovascular intervention. Even fewer outcome comparisons are available of QoL between open and endovascular revascularization for CLI indication.
Holtzman et al 13 evaluated 329 patients undergoing lower extremity angioplasty (36.8%), atherectomy (0.6%), surgical bypass (62.6%), or subsequent amputation (16.7%) during a 6-year period at the University of Minnesota with an average follow-up of 4.9 years. Of these patients, 63% were described as having a lower extremity skin ulcer, and 27% presented with rest pain. Overall survival was 37%, with a 73% limb salvage rate for those still alive at 7 years after the intervention. Diabetes and advanced age were negatively associated with physical health based on their HR-QoL assessments (SF-12 and SF-36). Surgical bypass as the index procedure was the only variable significantly associated with overall mental health, with bypass patients scoring nearly 5 points higher on the SF-12 mental health scores.
Patients with symptomatic peripheral arterial disease who underwent percutaneous transluminal angioplasty were evaluated by Kalbaugh et al 14 during a 4-month period. CLI was present in 36% of patients. The SF-36 health assessment survey was completed before the procedure and at 6 and 12 months after the procedure and demonstrated no improvement in any assessed variable except bodily pain and role limitation caused by emotional problems. Primary patency rates were 42% at 6 months and 35% at 1 year, with secondary patency rates of 68% at 6 months and 61% at 1 year. Limb salvage rates were 85% at 6 months and 77% at 1 year. Despite low patency rates, this patient population had reasonable limb salvage rates as well as good independence and ambulation maintenance rates at 1 year (87% and 76%, respectively). Thus, patients subjectively do not always describe improved QoL simply because they are still able to ambulate or live independently. Failed and redo catheter based procedures, like failed surgical procedures, may therefore also adversely affect QoL in the CLI patient despite high functional status, limb salvage, and maintained independence. The Bypass vs Angioplasty in Severe Ischaemia of the Leg (BASIL) trial compared the outcomes of amputation-free survival and overall survival after angioplasty vs surgery. 15 Physician-centered outcomes, such as graft patency, limb salvage, and survival, were similar between surgery and endovascular arms at short-term follow-up, but a significant advantage in these outcomes was seen at $2 years in the surgical arm.
The secondary end points of QoL and cost effectiveness were formally evaluated and separately published for the BASIL participants. 16 Multiple HR-QoL questionnaires were used for this analysis, including SF-36, VascuQol, and EQ-5D. These surveys were conducted at baseline and at multiple monthly intervals up to 3 years after randomization. All VascuQol domains demonstrated sustained improvement over the 36-month time frame, with the largest gains # 3 months after randomization and little change thereafter. The same was true for the SF-36 health domains and EQ-5D. No statistically significant differences were noted between the angioplasty and surgery groups. As in other studies, response rates were a problem. The overall response rate was 68%, with 93% of respondents completing their baseline survey, nearly 75% survey completion at 3 months and 1 year, and 35% survey completion at the 3-year follow-up.
FUTURE INVESTIGATION
Attrition is a significant limitation in quality assessment of CLI patients at long-term follow-up. A high rate of nonresponders can certainly confound interpretation of the QoL data. A commonly reported reason for nonresponse was the survey took too long to fill out. To this end, a shortened questionnaire, such as the SF-8 17 and
VascuQoL-6, 18 may improve compliance for assessing outcomes. CLI patients with no revascularization options have only rarely been studied with respect to QoL. Compared with claudicant patients and patients with cardiovascular risk factors (yet, without cardiovascular manifestations), this group demonstrated worse EQ-5D and SF-36 scores, particularly in the physical health, bodily pain, and mental health subscales. 19 Additional study is required to fully characterize this cohort's QoL to establish a useful baseline reference as well as further research to determine which interventions best fit which patients, provide biomedical advancements and cost-effective health care resource allocations, as well as potentially determine which subsets of CLI patients with revascularization options would instead benefit from more conservative management. Studies focusing on limb and life optimization rather than just limb salvage and survival are needed. The European Study Group on Diabetes and the Lower Extremity (Eurodiale) study prospectively observed patients with new diabetic foot ulcers (DFUs) over a span of 12 months. 20 These patients were managed according to the International Consensus on the Diabetic Foot protocols at 14 specialized diabetic foot clinics across Europe and assessed monthly until occurrence of a primary outcome, defined as healing (intact skin on the entire foot for two consecutive visits), major amputation, or death. Of the 1088 participants, the ulcer healed in >75%, 4.6% underwent subsequent major amputation, and 6.4% died during the follow-up period. EQ-5D QoL data were available in 93% and demonstrated HR-QoL was not independently related to healing but was independently related to subsequent major amputation and death in the follow-up period.
Although there are few reports regarding QoL in patients with DFUs, no reports focus on the interplay between CLI, DFUs, revascularization, and the associated effect on QoL. A growing body of literature indicates health disparities in CLI. Ethnic minorities disproportionately undergo amputation when admitted for CLI, 21 
CONCLUSIONS
Vascular reconstruction outcomes have traditionally been measured by objective clinical measures such as primary and secondary patency, limb salvage, and survival. In the 1990s, reports on CLI cohorts demonstrated a shift towards patient-reported measures of postsurgical revascularization functional or ambulatory status, or both. The paradigm continued to evolve toward the use of validated QoL instruments to evaluate other patient-centered outcomes, such as perceived pain, emotional and physical role functioning, vitality, mental health and other HR-QoL domains, after surgical or endovascular revascularization. However, in this patient population with multiple chronic and often debilitating comorbid conditions and high mortality rates, few reports have evaluated all of these outcomes after surgical bypass, endovascular interventions, or major amputation. And certainly, to date, no study has been fashioned to directly compare these groups using validated QoL instruments.
Although no strong conclusions can be made to guide clinical practice, it does appear that despite optimal limb salvage and revascularization patency rates, a reasonable functional status after intervention, and the ability to live and function independently after the procedure, patients do not always experience significant nor sustained gains in their HR-QoL (Table II) . It does, however, appear repeat procedures, whether open surgical or endovascular, likely adversely affect QoL. No particular revascularization type therefore can be favored over another toward a goal of improved QoL in CLI patients based on the literature currently available. Validated predictive models for assessing QoL in the CLI patient after revascularization are sorely needed to help guide treatment in this vulnerable population so that both physician-centered and patient-centered goals and outcomes can be attained. 
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